Key Insights

Highlights

Success Rate

90% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

7.3%

3 terminated out of 41 trials

Success Rate

89.7%

+3.2% vs benchmark

Late-Stage Pipeline

7%

3 trials in Phase 3/4

Results Transparency

19%

5 of 26 completed with results

Key Signals

5 with results90% success

Data Visualizations

Phase Distribution

24Total
Not Applicable (15)
P 1 (3)
P 2 (3)
P 4 (3)

Trial Status

Completed26
Recruiting6
Terminated3
Not Yet Recruiting3
Active Not Recruiting1
Unknown1

Trial Success Rate

89.7%

Benchmark: 86.5%

Based on 26 completed trials

Clinical Trials (41)

Showing 20 of 20 trials
NCT06388707Phase 1Recruiting

A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy

NCT04999046Not ApplicableCompleted

NaviFUS™ System Neuromodulating Treatment for Patients With Drug Resistant Epilepsy

NCT07508670Completed

An Observational Study of the NeuroBell EEG Monitor

NCT07451093Not ApplicableNot Yet Recruiting

Epileptiform Potential of Fully Immersive Virtual Reality

NCT07116330Recruiting

Late-Onset Seizures: Trial of Vascular Risk Investigation and Treatment

NCT07445074Not ApplicableRecruiting

AI-Based Mobile Intervention on Medication Non-Adherence and Transition

NCT07219407Phase 2Recruiting

A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures

NCT02694094Active Not Recruiting

Impact of Ketogenic Diets on Cardiovascular Health in Adults With Epilepsy

NCT07329257Recruiting

Investigating Phenotypic, Epigenetic, and NeuroGenetic Traits in Rare and Ultra-rare Neurodevelopmental Disorders (Project PENGUIN)

NCT07241754Not Yet Recruiting

Predictors of Drug Resistant Epilepsy Among Pediatric Patients

NCT06741930Phase 4Completed

Pro-Epileptic Effects of IV Ketamine

NCT06703983Not ApplicableCompletedPrimary

Efficacy of Low Glycemic Index Diet Versus Classic Ketogenic Diet in Pediatric Epilepsy Treatment

NCT07098728Not ApplicableRecruitingPrimary

Levetiracetam Versus Phenobarbital in Benzodiazepines Unresponsive Paediatric Prolonged Seizures

NCT05746624Completed

Procedural Motor Memory in Long COVID-19

NCT06723431Not Yet RecruitingPrimary

Assessment of Pre Hospital Rescue Intervention for Seizure in Pediatric Patients

NCT01801072Phase 4Completed

Seizure Prophylaxis in Aneurysm Repair

NCT05500638Not ApplicableCompleted

Effect of VR-ESMEPP on Parents' Seizure Management

NCT02334722Phase 4Completed

1 Week Versus 6 Weeks of Levetiracetam in Surgical Brain Tumor Patients

NCT02883712TerminatedPrimary

Study of Predictors of Response to Anti Epilepsy in Epilepsy

NCT02383745Completed

EEG in In-hospital Patients With Seizure or Altered Mental State

Scroll to load more

Research Network

Activity Timeline